Antimicrobial Resistance inHaemophilus influenzae
Top Cited Papers
- 1 April 2007
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 20 (2), 368-389
- https://doi.org/10.1128/cmr.00040-06
Abstract
Haemophilus influenzae is a major community-acquired pathogen causing significant morbidity and mortality worldwide. Meningitis and bacteremia due to type b strains occur in areas where the protein-conjugated type b vaccine is not in use, whereas nontypeable strains are major causes of otitis media, sinusitis, acute exacerbations of chronic bronchitis, and pneumonia. Antibiotic resistance in this organism is more diverse and widespread than is commonly appreciated. Intrinsic efflux resistance mechanisms limit the activity of the macrolides, azalides, and ketolides. beta-Lactamase production is highly prevalent worldwide and is associated with resistance to ampicillin and amoxicillin. Strains with alterations in penicillin binding proteins, particularly PBP3 (beta-lactamase negative ampicillin resistant and beta-lactamase positive amoxicillin-clavulanate resistant), are increasing in prevalence, particularly in Japan, with increasing resistance to ampicillin, amoxicillin, amoxicillin-clavulanate, and many cephalosporins, limiting the efficacy of expanded-spectrum cephalosporins against meningitis and of many oral cephalosporins against other diseases. Most strains remain susceptible to the carbapenems, which are not affected by penicillin binding protein changes, and the quinolones. The activity of many oral agents is limited by pharmacokinetics achieved with administration by this route, and the susceptibility of isolates based on pharmacokinetic and pharmacodynamic parameters is reviewed.Keywords
This publication has 164 references indexed in Scilit:
- EUCAST Technical Note on linezolidClinical Microbiology & Infection, 2006
- Molecular Evolution of β-Lactam-Resistant Haemophilus influenzae : 9-Year Surveillance of Penicillin-Binding Protein 3 Mutations in Isolates from JapanAntimicrobial Agents and Chemotherapy, 2006
- European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testingClinical Microbiology & Infection, 2006
- Characterization of a clinical isolate of Haemophilus influenzae with a high level of fluoroquinolone resistanceJournal of Antimicrobial Chemotherapy, 2006
- Variation in selected regions of blaTEM genes and promoters in Haemophilus influenzaeJournal of Antimicrobial Chemotherapy, 2005
- Possible High Rate of Transmission of Nontypeable Haemophilus influenzae , Including β-Lactamase-Negative Ampicillin-Resistant Strains, between Children and Their ParentsJournal of Clinical Microbiology, 2004
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Localization of the Escherichia coli cell division protein FtsI (PBP3) to the division site and cell poleMolecular Microbiology, 1997
- Development, characterization, and initial evaluations of S1 a new chromogenic cephalosporin for β-lactamase delectionDiagnostic Microbiology and Infectious Disease, 1995
- Molecular Epidemiology of Unrelated Clusters of Multiresistant Strains of Haemophilus influenzaeThe Journal of Infectious Diseases, 1992